February 15, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces it was notified today that Olivier Bohuon, Non-Executive Director of the Company, acquired 1,000 Ordinary Shares of 5 pence each in the Company (“Shares”) at an average price of £35.5212 per Share. The transaction took place on February 12, 2016, on the London Stock Exchange.
This notification is to satisfy the Company’s obligations under 3.1.4(R)(1)(a) of the Disclosure Rules and Transparency Rules.
Senior Assistant Company Secretary
For further information please contact:
|firstname.lastname@example.org||+1 781 482 9502|
|email@example.com||+44 1256 894157|
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.